NCT07537036 Analgesic Efficacy of Quadro-Iliac Plane Block Versus Erector Spinae Plane in Total Hip Arthroplasty
| NCT ID | NCT07537036 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Analgesic Efficacy |
| Study Type | INTERVENTIONAL |
| Enrollment | 76 participants |
| Start Date | 2026-04-18 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 76 participants in total. It began in 2026-04-18 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the Quadro-Iliac Plane Block versus Erector Spinae Plane Block after total hip arthroplasty.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-III. * Undergoing total hip arthroplasty (THA) under spinal anesthesia. Exclusion Criteria: * History of allergies to local anesthetics. * Opioid dependency. * Body mass index (BMI) \> 35 kg/m2. * Cognitive impairment. * Bleeding or coagulation disorders. * Psychiatric and neurological disorder. * Local infection at the site of injection. * Severe heart, lung, liver, and renal dysfunction. * Emergency surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07537036 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Analgesic Efficacy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07537036 currently recruiting?
Yes, NCT07537036 is actively recruiting participants. Contact the research team at mselsharkawy@med.tanta.edu.eg for enrollment information.
Where is the NCT07537036 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07537036 clinical trial?
NCT07537036 is sponsored by Tanta University. The trial plans to enroll 76 participants.